NCT03626142|Completed
Loading search results
Sponsor study identifier
observational
12
1 country
1
Study Start
July 9, 2018
Actual (reported)Primary Completion
April 4, 2023
Actual (reported)Study Completion
April 4, 2023
Actual (reported)This study will monitor the symptoms of patients who have received an intervention on the psychiatric inpatient unit at Stanford hospital up to 6 months after they have received the intervention. Additionally, the acceptability and feasibility of interventions will be assessed using clinician and patient questionnaires.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 4, 2023
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 6, 2018
Actual (reported)July 9, 2018
Actual (reported)August 10, 2018
Actual (reported)April 4, 2023
Actual (reported)April 4, 2023
Actual (reported)Montgomery-Asberg Depression Rating Scale (MADRS)
This is a ten-item clinician rated questionnaire in which the clinician rates each item from 0-6. Scores of 6 indicate more severe depressive symptoms. Total scores are between 0 and 60 with scores \>35 indicating severe depression. Response is defined as a 50% reduction or greater in MADRS score compared to baseline. Remission is defined as a MADRS score of \<10.
Weekly for first 4 weeks, followed by bi-weekly up until 24 weeks post-intervention
Scale for Suicide Ideation (SSI)
Weekly for first 4 weeks, followed by bi-weekly up until 24 weeks post-intervention
Beck Depression Inventory II (BDI-II)
Weekly for first 4 weeks, followed by bi-weekly up until 24 weeks post-intervention
Columbia-Suicide Severity Rating Scale (C-SSRS)
Weekly for first 4 weeks, followed by bi-weekly up until 24 weeks post-intervention
Young Mania Rating Scale (YMRS)
Weekly for first 4 weeks, followed by bi-weekly up until 8 weeks post-intervention.
Pittsburgh Insomnia Rating Scale (PIRS-20)
Weekly for first 4 weeks, followed by bi-weekly up until 8 weeks post-intervention.
Patients who have received accelerated theta burst stimulation delivered to the left dorsolateral prefrontal cortex on the inpatient unit at Stanford
Patients who have received accelerated theta burst stimulation delivered to the anterior cingulate cortex on the inpatient unit at Stanford
Patients who have received ECT on the inpatient unit at Stanford
Patients admitted to the psychiatric unit at Stanford University displaying depressive symptoms or suicidal ideation
Stanford Hospital
Palo Alto, California, 94305, United States
Kelly MS, Oliveira-Maia AJ, Bernstein M, Stern AP, Press DZ, Pascual-Leone A, Boes AD. Initial Response to Transcranial Magnetic Stimulation Treatment for Depression Predicts Subsequent Response. J Neuropsychiatry Clin Neurosci. 2017 Spring;29(2):179-182. doi: 10.1176/appi.neuropsych.16100181. Epub 2016 Nov 30.
Haq AU, Sitzmann AF, Goldman ML, Maixner DF, Mickey BJ. Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors. J Clin Psychiatry. 2015 Oct;76(10):1374-84. doi: 10.4088/JCP.14r09528.
Nolan Williams, MD
Stanford University
12 participants (actual enrollment reported by the registry).
First Submitted
July 6, 2018
First Posted
August 10, 2018
Study Start
July 9, 2018
Actual (reported)Observational Study to Compare Outcomes of Different Psychiatric Treatment of Suicidal Adolescents
Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation
Contact the study team to confirm eligibility.
Berggren A, Gustafson L, Hoglund P, Johanson A. A long-term follow-up of clinical response and regional cerebral blood flow changes in depressed patients treated with ECT. J Affect Disord. 2014;167:235-43. doi: 10.1016/j.jad.2014.06.005. Epub 2014 Jun 12.
Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2013 Aug 15;74(4):250-6. doi: 10.1016/j.biopsych.2012.06.022. Epub 2012 Jul 27.
Dell'osso B, D'Urso N, Castellano F, Ciabatti M, Altamura AC. Long-term efficacy after acute augmentative repetitive transcranial magnetic stimulation in bipolar depression: a 1-year follow-up study. J ECT. 2011 Jun;27(2):141-4. doi: 10.1097/YCT.0b013e3181f66601.
Primary Completion
April 4, 2023
Actual (reported)Study Completion
April 4, 2023
Actual (reported)Last Updated
October 28, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: